1. Carapetis JR et al. (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685–694
2. Bisno A et al. Rheumatic fever and rheumatic heart disease: report of a WHO Expert Consultation, Geneva, 29 October–1 November 2001. WHO Technical Report Series; 923. [
http://www.who.int/cardiovascular_diseases/resources/en/cvd_trs923.pdf
] (accessed 13 February 2008)
3. Council of Europe (online 10 October 1994) Recommendation No R(94)11 on screening as a tool of preventive medicine. [
http://www1.umn.edu/humanrts/instree/coerecr94-11.html
] (accessed 4 February 2008)
4. WHO (1999) The WHO Global Programme for the Prevention of Rheumatic Fever and Rheumatic Heart Disease: Report of a consultation to review progress and develop future activities Geneva, November 29–December 1 [
http://whqlibdoc.who.int/hq/2000/WHO_CVD_00.1.pdf
] (accessed 13 February 2008)
5. Jaffe WM et al. (1988) Clinical evaluation versus Doppler echocardiography in the quantitative assessment of valvular heart disease. Circulation 78: 267–275